Proceedings of the National Academy of Sciences of the United States of America, Vol. 87, No. 17 (Sep., 1990), pp. 6772-6776 (5 pages) We developed vector plasmids for the transformation of ...
Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback